These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 1996588)
21. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [TBL] [Abstract][Full Text] [Related]
22. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients. Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor. Weir MR; Lavin PT; Byrnes CA Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944 [TBL] [Abstract][Full Text] [Related]
24. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM. Puig JG; Calvo C; Luurila O; Luurila H; Sulosaari S; Strandberg A; Ghezzi C J Hum Hypertens; 2007 Dec; 21(12):917-24. PubMed ID: 17581601 [TBL] [Abstract][Full Text] [Related]
25. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
26. Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension. Tomlinson B; Woo J; Thomas GN; Chau YM; Critchley JA Clin Ther; 2004 Aug; 26(8):1292-304. PubMed ID: 15476910 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Williams GH; Burgess E; Kolloch RE; Ruilope LM; Niegowska J; Kipnes MS; Roniker B; Patrick JL; Krause SL Am J Cardiol; 2004 Apr; 93(8):990-6. PubMed ID: 15081441 [TBL] [Abstract][Full Text] [Related]
28. Mild hypertension in the elderly. A comparison of prazosin and enalapril. Cheung DG; Hoffman CA; Ricci ST; Weber MA Am J Med; 1989 Jan; 86(1B):87-90. PubMed ID: 2536516 [TBL] [Abstract][Full Text] [Related]
29. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259 [TBL] [Abstract][Full Text] [Related]
30. Labetalol and nifedipine in the management of essential hypertension. Prasad NK J Indian Med Assoc; 1990 Jul; 88(7):188-9. PubMed ID: 2266262 [TBL] [Abstract][Full Text] [Related]
31. ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension. Amerena J; Pappas S; Ouellet JP; Williams L; O'Shaughnessy D J Int Med Res; 2002; 30(6):543-52. PubMed ID: 12526280 [TBL] [Abstract][Full Text] [Related]
32. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril. Milovanovic B; Trifunovic D; Djuric D Acta Physiol Hung; 2011 Mar; 98(1):71-84. PubMed ID: 21388933 [TBL] [Abstract][Full Text] [Related]
33. Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes. Neutel JM; Kereiakes DJ; Waverczak WF; Stoakes KA; Xu J; Shojaee A Curr Med Res Opin; 2010 Mar; 26(3):721-8. PubMed ID: 20085534 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study. Tomei R; Rossi L; Carbonieri E; Franceschini L; Molon G; Zardini P J Cardiovasc Pharmacol; 1992 Jun; 19(6):911-4. PubMed ID: 1376812 [TBL] [Abstract][Full Text] [Related]
35. Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension. Abernethy DR; Schwartz JB; Plachetka JR; Todd EL; Egan JM Am J Cardiol; 1987 Sep; 60(8):697-702. PubMed ID: 3661438 [TBL] [Abstract][Full Text] [Related]
36. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
37. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
38. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients. Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760 [TBL] [Abstract][Full Text] [Related]
39. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group. Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990 [TBL] [Abstract][Full Text] [Related]
40. Duration of the antihypertensive action of atenolol, enalapril and placebo: a randomized within-patient study using ambulatory blood pressure monitoring. Verdecchia P; Gatteschi C; Benemio G; Boldrini F; Guerrieri M; Porcellati C Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):570-4. PubMed ID: 2854116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]